Dasatinib (for Ph+ ALL)
Treatment used for 1 condition
Total Trials
35
Total Participants
10K
Avg Effectiveness
88%
Avg Safety Score
55%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.
Treatment used for 1 condition
Click on a condition to view detailed treatment information and clinical trial data.